Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
2,267
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
2,267
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2021-01-04 23:10 | Report Abuse
MYR very strong now
Stock
2021-01-04 23:09 | Report Abuse
Accumulating this counter since last week
Stock
2021-01-04 23:08 | Report Abuse
Buy buy buy Brent wow....oil up to 53 now... will continue up
Stock
Stock
2021-01-04 23:01 | Report Abuse
Now TG boss sell... u buy then masuk kandang
Stock
2021-01-04 22:58 | Report Abuse
Very good counter
Stock
2021-01-04 14:38 | Report Abuse
Short term Should over RM5. Long term should over RM7.00 and over
Stock
Stock
2021-01-04 10:00 | Report Abuse
Finally JP Morgan the forecast Tp 3.50 was accurate l
Stock
2021-01-04 09:53 | Report Abuse
Then u sendiri goreng sendiri song
Stock
2021-01-04 09:53 | Report Abuse
Uncle lim please sapu.. we all wanna sell now & sold
Stock
Stock
Stock
Stock
Stock
2021-01-01 11:48 | Report Abuse
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
Stock
2021-01-01 11:48 | Report Abuse
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
Stock
2021-01-01 11:47 | Report Abuse
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
Stock
2021-01-01 11:47 | Report Abuse
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
Stock
2021-01-01 11:47 | Report Abuse
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
Stock
2021-01-01 00:23 | Report Abuse
Myeg, all those penny stock or stock with good fundamental earn more than 100% or more, wish u can do it then same in year 2021
Happy new year guys,
Wish u all good health and earn more money, huat ahhh
Stock
2021-01-01 00:22 | Report Abuse
Myeg, all those penny stock or stock with good fundamental earn more than 100% or more, wish u can do it then same in year 2021
Happy new year guys,
Wish u all good health and earn more money, huat ahhh
Stock
2020-12-31 21:34 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:34 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:34 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:32 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:31 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:31 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
2020-12-31 21:21 | Report Abuse
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
Stock
Stock
Stock
2020-12-31 16:27 | Report Abuse
GST 重启势在必行
NiiS 还未明确公布
智飞疫苗EPF 庞大资金入驻
二月业绩 又破新高
MYEG 展望未来
Happy new year 2021
Stock
2020-12-31 16:27 | Report Abuse
GST 重启势在必行
NiiS 还未明确公布
智飞疫苗EPF 庞大资金入驻
二月业绩 又破新高
MYEG 展望未来
Happy new year 2021
Stock
2020-12-31 16:26 | Report Abuse
GST 重启势在必行
NiiS 还未明确公布
智飞疫苗EPF 庞大资金入驻
二月业绩 又破新高
MYEG 展望未来
Happy new year 2021
Stock
2020-12-31 16:25 | Report Abuse
GST 重启势在必行
NiiS 还未明确公布
智飞疫苗EPF 庞大资金入驻
二月业绩 又破新高
MYEG 展望未来
Happy new year 2021
Stock
Stock
Stock
Stock
Stock
Stock
2020-12-31 15:03 | Report Abuse
Telusdamsuci love u @ Cheers happy new year 2021.
Stock
Stock
2020-12-31 14:58 | Report Abuse
See boss acquire more today & EPF continue throw
Stock
2020-12-31 14:54 | Report Abuse
Gg. Boss sendiri goreng sendiri syiok
Stock
2020-12-31 14:53 | Report Abuse
Mother n kid pmetal n Pmbtech boleh boleh go go go go go
Stock
2020-12-30 23:37 | Report Abuse
Fraud syndicates harvesting information from govt portals — Bukit Aman - http://www.theedgemarkets.com/article/fraud-syndicates-harvesting-information-govt-portals-—-bukit-aman (Share from StockHunter)
Stock
Stock
Stock
Stock: [HENGYUAN]: HENGYUAN REFINING COMPANY BERHAD
2021-01-04 23:13 | Report Abuse
Tp 0ver 9: